AT

Alpa Tyagi

Active Director Director DIN 10410677
DIN 10410677 First appointment Nov 2023 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value •••• Premium profile

About Alpa Tyagi

Data last updated:

Alpa Tyagi is a Director at Pfarmacia Genomes Private Limited (since 2023). The company operates in Healthcare. Pfarmacia Genomes Private Limited reported revenue of ₹10.4 Lakh (FY 2024).

DIN 10410677
Primary Designation Director
Industry Healthcare
First Appointment 30 Nov 2023
Oldest Company Age 2 yrs
Largest company Pfarmacia Genomes Private Limited · ₹10.4 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pfarmacia Genomes Private Limited U75000UP2023PTC193303
Director30 Nov 20232023₹10.4 Lakh (FY 2024)Active

Board colleagues of Alpa Tyagi

NameDINCompanyDesignation
Bhupendra Kumar Tyagi06978083Pfarmacia Genomes Private LimitedDirector

Directorship timeline

Open interactive timeline →
Pfarmacia Genomes Private Limited
Premium access

Shareholding and investment profile for Alpa Tyagi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Alpa Tyagi

Alpa Tyagi currently holds 1 directorship: Pfarmacia Genomes Private Limited (Director, since 30 Nov 2023, revenue ₹10.4 Lakh (FY 2024)).

Alpa Tyagi was first appointed on 30 Nov 2023 as Director at Pfarmacia Genomes Private Limited.

The current boards of Alpa Tyagi's companies include Bhupendra Kumar Tyagi (Pfarmacia Genomes Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available